Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05130866
Title Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas (POPLAR-NF2)
Acronym POPLAR-NF2
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Recursion Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
House Institute RECRUITING Los Angeles California 90057 United States Details
University of California Los Angeles RECRUITING Los Angeles California 90095 United States Details
Children's National Hospital RECRUITING Washington District of Columbia 20010 United States Details
University of Florida RECRUITING Gainesville Florida 32611 United States Details
Nicklaus Children's Hospital RECRUITING Miami Florida 33155 United States Details
Sarah Cannon Cancer Institute - HCA Midwest ACTIVE_NOT_RECRUITING Overland Park Kansas 66211 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center RECRUITING Boston Massachusetts 02215 United States Details
University of Minnesota / Masonic Cancer Center RECRUITING Minneapolis Minnesota 55455 United States Details
Mayo Clinic RECRUITING Rochester Minnesota 55905 United States Details
Columbia University RECRUITING New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Duke University Medical Center RECRUITING Durham North Carolina 27710 United States Details
UT Southwestern Medical Center RECRUITING Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field